Funder: Pfizer Inc.
Due Dates: July 4, 2025 (LOI deadline) | June 15, 2026 (Application deadline, 23:59 EST)
Funding Amounts: Up to 1,200,000 JPY per project (includes direct and indirect costs, max 28% overhead); project duration up to 2 years.
Summary: Supports Japanese organizational projects that improve migraine care through early diagnosis, education, and healthcare collaboration.
Key Information: Only organizations (not individuals) in Japan are eligible; projects must focus on quality improvement, not clinical research.